Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients

被引：0
|
作者：
Pyry Antti Välitalo
Tuula Ahtola-Sätilä
Andrew Wighton
Toni Sarapohja
Pasi Pohjanjousi
Chris Garratt
机构：
[1] University of Eastern Finland,Faculty of Health Sciences, School of Pharmacy
[2] Orion Pharma,undefined
[3] Orion Pharma,undefined
来源：
Clinical Drug Investigation | 2013年 / 33卷
关键词：
Intensive Care Unit Patient; Dexmedetomidine; Hepatic Blood Flow; Simplify Acute Physiology Score; Intensive Care Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：579 / 587
页数：8
相关论文
共 50 条
  • [1] Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients
    Valitalo, Pyry Antti
    Ahtola-Satila, Tuula
    Wighton, Andrew
    Sarapohja, Toni
    Pohjanjousi, Pasi
    Garratt, Chris
    [J]. CLINICAL DRUG INVESTIGATION, 2013, 33 (08) : 579 - 587
  • [2] Protein Binding and Population Pharmacokinetics of Dexmedetomidine after Prolonged Infusions in Adult Critically Ill Patients
    Yan, Xiaoyu
    Tse, Andrew Ho Wai
    Lee, Anna
    Zhang, Lin
    Yang, Mengbi
    Zuo, Zhong
    Joynt, Gavin Matthew
    [J]. CLINICAL THERAPEUTICS, 2021, 43 (08) : 1356 - +
  • [3] Population Pharmacokinetics of Ganciclovir in Critically Ill Patients
    Krens, Stefanie D.
    Hodiamont, Caspar J.
    Juffermans, Nicole P.
    Mathot, Ron A. A.
    van Hest, Reinier M.
    [J]. THERAPEUTIC DRUG MONITORING, 2020, 42 (02) : 295 - 301
  • [4] Population pharmacokinetics of daptomycin in critically ill patients
    Soraluce, A.
    Asin-Prieto, E.
    Rodriguez-Gascon, A.
    Barrasa, H.
    Maynar, J.
    Carcelero, E.
    Soy, D.
    Isla, A.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 52 (02) : 158 - 165
  • [5] Population Pharmacokinetics of Fosfomycin in Critically Ill Patients
    Parker, Suzanne L.
    Frantzeskaki, Frantzeska
    Wallis, Steven C.
    Diakaki, Chryssa
    Giamarellou, Helen
    Koulenti, Despoina
    Karaiskos, Ilias
    Lipman, Jeffrey
    Dimopoulos, George
    Roberts, Jason A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (10) : 6471 - 6476
  • [6] Population pharmacokinetics of amikacin in critically ill patients
    Bressolle, F
    Gouby, A
    Martinez, JM
    Joubert, P
    Saissi, G
    Guillaud, R
    Gomeni, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (07) : 1682 - 1689
  • [7] Population pharmacokinetics of meropenem in critically ill patients
    Rancic, Aleksandar
    Milosavljevic, Milos N.
    Rosic, Nikola
    Milovanovic, Dragan
    Folic, Marko
    Zecevic, Dejana Ruzic
    Petrovic, Nemanja
    Corbic, Mirjana Milojevic
    Dabanovic, Vera
    Jankovic, Slobodan M.
    [J]. OPEN MEDICINE, 2024, 19 (01):
  • [8] Population pharmacokinetics of tigecycline in critically ill patients
    Luo, Xiangru
    Wang, Shiyi
    Li, Dong
    Wen, Jun
    Sun, Na
    Fan, Guangjun
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [9] POPULATION PHARMACOKINETICS OF DEXMEDETOMIDINE DURING LONG-TERM CONTINUOUS INFUSION IN CRITICALLY ILL PATIENTS.
    Fiedler-Kelly, J. B.
    Ludwig, E. A.
    Lu, Q.
    Stalker, D. J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S60 - S60
  • [10] Population pharmacokinetics of meropenem in critically ill infant patients
    Yonwises, Wanlika
    Wacharachaisurapol, Noppadol
    Anugulruengkitt, Suvaporn
    Maimongkol, Passara
    Treyaprasert, Wanchai
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 111 : 58 - 64
12345